2-Oxo-tetrahydro-1,8-naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarials

被引:64
作者
Olepu, Srinivas [1 ]
Suryadevara, Praveen Kumar [1 ]
Rivas, Kasey [2 ]
Yokoyama, Kohei [1 ]
Verlinde, Christophe L. M. J. [3 ]
Chakrabarti, Debopam [4 ]
Van Voorhis, Wesley C. [2 ]
Gelb, Michael H. [1 ,3 ]
机构
[1] Univ Washington, Dept Chem, Seattle, WA 98195 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[4] Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA
关键词
malaria; P; falciparum; anti-malarials; protein farnesyl-transferase; drug discovery; rational drug design;
D O I
10.1016/j.bmcl.2007.11.104
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new class of 2-oxo-tetrahydro-1,8-naphthyridine-based protein farnesyltransferase inhibitors were synthesized and found to inhibit protein farnesyltransferase from the malaria parasite with potencies in the low nanomolar range. The compounds were much less potent on mammalian protein prenyltransferases. Two of the compounds block the growth of malaria in culture with potencies in the sub-micromolar range. Some of the compounds were found to be much more metabolically stable than previously described tetrahydroquinoline-based protein farnesyltransferase inhibitors. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:494 / 497
页数:4
相关论文
共 8 条
[1]   Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials [J].
Bendale, Pravin ;
Olepu, Srinivas ;
Suryadevara, Praveen Kumar ;
Bulbule, Vivek ;
Rivas, Kasey ;
Nallan, Laxman ;
Smart, Brian ;
Yokoyama, Kohei ;
Ankala, Sudha ;
Pendyala, Prakash Rao ;
Floyd, David ;
Lombardo, Louis J. ;
Williams, David K. ;
Buckner, Frederick S. ;
Chakrabarti, Debopam ;
Verlinde, Christophe L. M. J. ;
Van Voorhis, Wesley C. ;
Gelb, Michael H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (19) :4585-4605
[2]  
Buckner Frederick S, 2005, Curr Opin Investig Drugs, V6, P791
[3]   Fighting parasitic disease by blocking protein farnesylation [J].
Eastman, RT ;
Buckner, FS ;
Yokoyama, K ;
Gelb, MH ;
Van Voorhis, WC .
JOURNAL OF LIPID RESEARCH, 2006, 47 (02) :233-240
[4]   Therapeutic intervention based on protein prenylation and associated modifications [J].
Gelb, Michael H. ;
Brunsveld, Lucas ;
Hrycyna, Christine A. ;
Michaelis, Susan ;
Tamanoi, Fuyuhiko ;
Van Voorhis, Wesley C. ;
Waldmann, Herbert .
NATURE CHEMICAL BIOLOGY, 2006, 2 (10) :518-528
[5]   Protein farnesyltransferase inhibitors exhibit potent antimalarial activity [J].
Nallan, L ;
Bauer, KD ;
Bendale, P ;
Rivas, K ;
Yokoyama, K ;
Hornéy, CP ;
Pendyala, PR ;
Floyd, D ;
Lombardo, LJ ;
Williams, DK ;
Hamilton, A ;
Sebti, S ;
Windsor, WT ;
Weber, PC ;
Buckner, FS ;
Chakrabarti, D ;
Gelb, MH ;
Van Voorhis, WC .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (11) :3704-3713
[6]   Innovative lead discovery strategies for tropical diseases [J].
Nwaka, Solomon ;
Hudson, Alan .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (11) :941-955
[7]   Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase [J].
Van Voorhis, Wesley C. ;
Rivas, Kasey L. ;
Bendale, Pravin ;
Nallan, Laxman ;
Horney, Carolyn ;
Barrett, Lynn K. ;
Bauer, Kevin D. ;
Smart, Brian P. ;
Ankala, Sudha ;
Hucke, Oliver ;
Verlinde, Christophe L. M. J. ;
Chakrabarti, Debopam ;
Strickland, Corey ;
Yokoyama, Kohei ;
Buckner, Frederick S. ;
Hamilton, Andrew D. ;
Williams, David K. ;
Lombardo, Louis J. ;
Floyd, David ;
Gelb, Michael H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) :3659-3671
[8]   Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation [J].
Yokoyama, K ;
Zimmerman, K ;
Scholten, J ;
Gelb, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) :3944-3952